A Study of VIS410 to Assess Safety and Pharmacokinetics

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

May 31, 2015

Study Completion Date

May 31, 2015

Conditions

Influenza

Interventions

DRUG

VIS410

DRUG

Placebo

Trial Locations (1)

DaVita Clinical Research, Minneapolis

All Listed Sponsors

lead

Visterra, Inc.

INDUSTRY

NCT02045472 - A Study of VIS410 to Assess Safety and Pharmacokinetics | Biotech Hunter | Biotech Hunter